Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
MX:JNJ
Stock Latest News
The Fly
Johnson & Johnson’s Imaavy shows efficacy in gMG Phase 2/3 trial
14h ago
JNJ
Premium
The Fly
Johnson & Johnson price target raised to $285 from $270 at JPMorgan
15h ago
JNJ
Premium
The Fly
Johnson & Johnson price target raised to $278 from $263 at BofA
16h ago
JNJ
Premium
The Fly
Johnson & Johnson says Tremfya met endpoints in Phase 4 STAR study
5d ago
JNJ
Premium
The Fly
Johnson & Johnson reports new long-term data from Phase 2 CARTITUDE-2 study
5d ago
JNJ
Premium
The Fly
Johnson & Johnson: Phase 3 MajesTEC-3 study shows ‘sustained’ disease control
7d ago
JNJ
Premium
The Fly
DePuy Synthes showcass trauma innovations at OTA 2026
8d ago
JNJ
Premium
Ratings
Michael Yee Reiterates Buy on JNJ, Maintains $320 Price Target on Caplyta’s Strong Bipolar Mania Prospects
8d ago
JNJ
Premium
The Fly
Trump Trade: U.S. announces deal with Denmark over Greenland’s security
9d ago
AZN
BMY
Premium
The Fly
J&J says Caplyta Phase 3 study in bipolar I met primary endpoint
9d ago
JNJ
Premium
The Fly
Johnson & Johnson announces ‘positive’ results from Phase 3 trial of Caplyta
9d ago
JNJ
Premium
The Fly
U.S. weighs allowing most pharma licensing deals with China, Reuters says
11d ago
AZN
BMY
Premium
The Fly
PepsiCo names Joaquin Duato to Board of Directors
12d ago
JNJ
PEP
Premium
The Fly
Nanobiotix assumed with a Buy at Guggenheim
15d ago
JNJ
NBTX
Premium
The Fly
Johnson & Johnson announces new results from COPERNICUS study
15d ago
JNJ
Premium
Ratings
J&J: Oncology Momentum and Potential $20B DePuy Synthes Divestiture Support Nedelcovych Buy Rating
15d ago
JNJ
Premium
The Fly
Contineum says MOONLIGHT-1 trial did not achieve its primary endpoint
15d ago
JNJ
CTNM
Premium
The Fly
Johnson & Johnson reports PAPILLON study meets primary endpoint
16d ago
JNJ
Premium
The Fly
Nanobiotix announces updated safety, efficacy data from JNJ-1900 study
16d ago
JNJ
NBTX
Premium
The Fly
Apollo Global in talks to buy J&J’s orthopedics unit, Bloomberg reports
18d ago
APO
JNJ
Premium
The Fly
Apollo Global in discussions to buy JNJ’s orthopedics unit, Bloomberg reports
18d ago
APO
JNJ
Premium
The Fly
Johnson & Johnson receives CE Marking for ACUVUE OASYS MAX
20d ago
JNJ
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
